On 18 May 2025, at the American Thoracic Society International Conference, held in San Francisco, California, post hoc findings from the Phase IIa COURSE trial (NCT04039113) shed light on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback